Global Human Factor VIII Concentrate Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Human Factor VIII Concentrate market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Complementary therapy for prevention and treatment of hemophilia A acquired coagulation factor ? deficiency and von Willebrand's disease
This report is a detailed and comprehensive analysis for global Human Factor VIII Concentrate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Factor VIII Concentrate market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Factor VIII Concentrate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Factor VIII Concentrate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Factor VIII Concentrate market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Factor VIII Concentrate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Factor VIII Concentrate market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Novo Nordisk A/S, Shire (Baxter), Bayer and GC Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Factor VIII Concentrate market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Human Factor VIII Concentrate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Factor VIII Concentrate, with price, sales, revenue and global market share of Human Factor VIII Concentrate from 2018 to 2023.
Chapter 3, the Human Factor VIII Concentrate competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Factor VIII Concentrate breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Factor VIII Concentrate market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Factor VIII Concentrate.
Chapter 14 and 15, to describe Human Factor VIII Concentrate sales channel, distributors, customers, research findings and conclusion.
Complementary therapy for prevention and treatment of hemophilia A acquired coagulation factor ? deficiency and von Willebrand's disease
This report is a detailed and comprehensive analysis for global Human Factor VIII Concentrate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Factor VIII Concentrate market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Factor VIII Concentrate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Factor VIII Concentrate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Factor VIII Concentrate market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Factor VIII Concentrate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Factor VIII Concentrate market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Novo Nordisk A/S, Shire (Baxter), Bayer and GC Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Factor VIII Concentrate market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Blood Extraction
- Recombine
- Congenital Coagulation Factor VIII Deficiency
- Acquired Factor VIII Deficiency
- Von Willebrand's Disease
- Pfizer
- Novo Nordisk A/S
- Shire (Baxter)
- Bayer
- GC Pharma
- Shanghai Raas Corp
- Hualan Biological
- Shandong Taibang Biological Products
- Shanghai Xinxing Medicine
- SinoCell Tech
- CSL
- Grifols
- Biogen
- Octapharma
- NovoNordisk
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Human Factor VIII Concentrate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Factor VIII Concentrate, with price, sales, revenue and global market share of Human Factor VIII Concentrate from 2018 to 2023.
Chapter 3, the Human Factor VIII Concentrate competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Factor VIII Concentrate breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Factor VIII Concentrate market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Factor VIII Concentrate.
Chapter 14 and 15, to describe Human Factor VIII Concentrate sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Human Factor VIII Concentrate
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Factor VIII Concentrate Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Blood Extraction
1.3.3 Recombine
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Factor VIII Concentrate Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Congenital Coagulation Factor VIII Deficiency
1.4.3 Acquired Factor VIII Deficiency
1.4.4 Von Willebrand's Disease
1.5 Global Human Factor VIII Concentrate Market Size & Forecast
1.5.1 Global Human Factor VIII Concentrate Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Factor VIII Concentrate Sales Quantity (2018-2029)
1.5.3 Global Human Factor VIII Concentrate Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Human Factor VIII Concentrate Product and Services
2.1.4 Pfizer Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Novo Nordisk A/S
2.2.1 Novo Nordisk A/S Details
2.2.2 Novo Nordisk A/S Major Business
2.2.3 Novo Nordisk A/S Human Factor VIII Concentrate Product and Services
2.2.4 Novo Nordisk A/S Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novo Nordisk A/S Recent Developments/Updates
2.3 Shire (Baxter)
2.3.1 Shire (Baxter) Details
2.3.2 Shire (Baxter) Major Business
2.3.3 Shire (Baxter) Human Factor VIII Concentrate Product and Services
2.3.4 Shire (Baxter) Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shire (Baxter) Recent Developments/Updates
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Human Factor VIII Concentrate Product and Services
2.4.4 Bayer Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer Recent Developments/Updates
2.5 GC Pharma
2.5.1 GC Pharma Details
2.5.2 GC Pharma Major Business
2.5.3 GC Pharma Human Factor VIII Concentrate Product and Services
2.5.4 GC Pharma Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GC Pharma Recent Developments/Updates
2.6 Shanghai Raas Corp
2.6.1 Shanghai Raas Corp Details
2.6.2 Shanghai Raas Corp Major Business
2.6.3 Shanghai Raas Corp Human Factor VIII Concentrate Product and Services
2.6.4 Shanghai Raas Corp Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Shanghai Raas Corp Recent Developments/Updates
2.7 Hualan Biological
2.7.1 Hualan Biological Details
2.7.2 Hualan Biological Major Business
2.7.3 Hualan Biological Human Factor VIII Concentrate Product and Services
2.7.4 Hualan Biological Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hualan Biological Recent Developments/Updates
2.8 Shandong Taibang Biological Products
2.8.1 Shandong Taibang Biological Products Details
2.8.2 Shandong Taibang Biological Products Major Business
2.8.3 Shandong Taibang Biological Products Human Factor VIII Concentrate Product and Services
2.8.4 Shandong Taibang Biological Products Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Shandong Taibang Biological Products Recent Developments/Updates
2.9 Shanghai Xinxing Medicine
2.9.1 Shanghai Xinxing Medicine Details
2.9.2 Shanghai Xinxing Medicine Major Business
2.9.3 Shanghai Xinxing Medicine Human Factor VIII Concentrate Product and Services
2.9.4 Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Shanghai Xinxing Medicine Recent Developments/Updates
2.10 SinoCell Tech
2.10.1 SinoCell Tech Details
2.10.2 SinoCell Tech Major Business
2.10.3 SinoCell Tech Human Factor VIII Concentrate Product and Services
2.10.4 SinoCell Tech Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 SinoCell Tech Recent Developments/Updates
2.11 CSL
2.11.1 CSL Details
2.11.2 CSL Major Business
2.11.3 CSL Human Factor VIII Concentrate Product and Services
2.11.4 CSL Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CSL Recent Developments/Updates
2.12 Grifols
2.12.1 Grifols Details
2.12.2 Grifols Major Business
2.12.3 Grifols Human Factor VIII Concentrate Product and Services
2.12.4 Grifols Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Grifols Recent Developments/Updates
2.13 Biogen
2.13.1 Biogen Details
2.13.2 Biogen Major Business
2.13.3 Biogen Human Factor VIII Concentrate Product and Services
2.13.4 Biogen Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Biogen Recent Developments/Updates
2.14 Octapharma
2.14.1 Octapharma Details
2.14.2 Octapharma Major Business
2.14.3 Octapharma Human Factor VIII Concentrate Product and Services
2.14.4 Octapharma Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Octapharma Recent Developments/Updates
2.15 NovoNordisk
2.15.1 NovoNordisk Details
2.15.2 NovoNordisk Major Business
2.15.3 NovoNordisk Human Factor VIII Concentrate Product and Services
2.15.4 NovoNordisk Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 NovoNordisk Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN FACTOR VIII CONCENTRATE BY MANUFACTURER
3.1 Global Human Factor VIII Concentrate Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Factor VIII Concentrate Revenue by Manufacturer (2018-2023)
3.3 Global Human Factor VIII Concentrate Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Factor VIII Concentrate by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Factor VIII Concentrate Manufacturer Market Share in 2022
3.4.2 Top 6 Human Factor VIII Concentrate Manufacturer Market Share in 2022
3.5 Human Factor VIII Concentrate Market: Overall Company Footprint Analysis
3.5.1 Human Factor VIII Concentrate Market: Region Footprint
3.5.2 Human Factor VIII Concentrate Market: Company Product Type Footprint
3.5.3 Human Factor VIII Concentrate Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Factor VIII Concentrate Market Size by Region
4.1.1 Global Human Factor VIII Concentrate Sales Quantity by Region (2018-2029)
4.1.2 Global Human Factor VIII Concentrate Consumption Value by Region (2018-2029)
4.1.3 Global Human Factor VIII Concentrate Average Price by Region (2018-2029)
4.2 North America Human Factor VIII Concentrate Consumption Value (2018-2029)
4.3 Europe Human Factor VIII Concentrate Consumption Value (2018-2029)
4.4 Asia-Pacific Human Factor VIII Concentrate Consumption Value (2018-2029)
4.5 South America Human Factor VIII Concentrate Consumption Value (2018-2029)
4.6 Middle East and Africa Human Factor VIII Concentrate Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Factor VIII Concentrate Sales Quantity by Type (2018-2029)
5.2 Global Human Factor VIII Concentrate Consumption Value by Type (2018-2029)
5.3 Global Human Factor VIII Concentrate Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Factor VIII Concentrate Sales Quantity by Application (2018-2029)
6.2 Global Human Factor VIII Concentrate Consumption Value by Application (2018-2029)
6.3 Global Human Factor VIII Concentrate Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Human Factor VIII Concentrate Sales Quantity by Type (2018-2029)
7.2 North America Human Factor VIII Concentrate Sales Quantity by Application (2018-2029)
7.3 North America Human Factor VIII Concentrate Market Size by Country
7.3.1 North America Human Factor VIII Concentrate Sales Quantity by Country (2018-2029)
7.3.2 North America Human Factor VIII Concentrate Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Human Factor VIII Concentrate Sales Quantity by Type (2018-2029)
8.2 Europe Human Factor VIII Concentrate Sales Quantity by Application (2018-2029)
8.3 Europe Human Factor VIII Concentrate Market Size by Country
8.3.1 Europe Human Factor VIII Concentrate Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Factor VIII Concentrate Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Factor VIII Concentrate Market Size by Region
9.3.1 Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Factor VIII Concentrate Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Human Factor VIII Concentrate Sales Quantity by Type (2018-2029)
10.2 South America Human Factor VIII Concentrate Sales Quantity by Application (2018-2029)
10.3 South America Human Factor VIII Concentrate Market Size by Country
10.3.1 South America Human Factor VIII Concentrate Sales Quantity by Country (2018-2029)
10.3.2 South America Human Factor VIII Concentrate Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Factor VIII Concentrate Market Size by Country
11.3.1 Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Factor VIII Concentrate Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Human Factor VIII Concentrate Market Drivers
12.2 Human Factor VIII Concentrate Market Restraints
12.3 Human Factor VIII Concentrate Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Factor VIII Concentrate and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Factor VIII Concentrate
13.3 Human Factor VIII Concentrate Production Process
13.4 Human Factor VIII Concentrate Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Factor VIII Concentrate Typical Distributors
14.3 Human Factor VIII Concentrate Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Human Factor VIII Concentrate
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Factor VIII Concentrate Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Blood Extraction
1.3.3 Recombine
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Factor VIII Concentrate Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Congenital Coagulation Factor VIII Deficiency
1.4.3 Acquired Factor VIII Deficiency
1.4.4 Von Willebrand's Disease
1.5 Global Human Factor VIII Concentrate Market Size & Forecast
1.5.1 Global Human Factor VIII Concentrate Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Factor VIII Concentrate Sales Quantity (2018-2029)
1.5.3 Global Human Factor VIII Concentrate Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Human Factor VIII Concentrate Product and Services
2.1.4 Pfizer Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Novo Nordisk A/S
2.2.1 Novo Nordisk A/S Details
2.2.2 Novo Nordisk A/S Major Business
2.2.3 Novo Nordisk A/S Human Factor VIII Concentrate Product and Services
2.2.4 Novo Nordisk A/S Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novo Nordisk A/S Recent Developments/Updates
2.3 Shire (Baxter)
2.3.1 Shire (Baxter) Details
2.3.2 Shire (Baxter) Major Business
2.3.3 Shire (Baxter) Human Factor VIII Concentrate Product and Services
2.3.4 Shire (Baxter) Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shire (Baxter) Recent Developments/Updates
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Human Factor VIII Concentrate Product and Services
2.4.4 Bayer Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer Recent Developments/Updates
2.5 GC Pharma
2.5.1 GC Pharma Details
2.5.2 GC Pharma Major Business
2.5.3 GC Pharma Human Factor VIII Concentrate Product and Services
2.5.4 GC Pharma Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GC Pharma Recent Developments/Updates
2.6 Shanghai Raas Corp
2.6.1 Shanghai Raas Corp Details
2.6.2 Shanghai Raas Corp Major Business
2.6.3 Shanghai Raas Corp Human Factor VIII Concentrate Product and Services
2.6.4 Shanghai Raas Corp Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Shanghai Raas Corp Recent Developments/Updates
2.7 Hualan Biological
2.7.1 Hualan Biological Details
2.7.2 Hualan Biological Major Business
2.7.3 Hualan Biological Human Factor VIII Concentrate Product and Services
2.7.4 Hualan Biological Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hualan Biological Recent Developments/Updates
2.8 Shandong Taibang Biological Products
2.8.1 Shandong Taibang Biological Products Details
2.8.2 Shandong Taibang Biological Products Major Business
2.8.3 Shandong Taibang Biological Products Human Factor VIII Concentrate Product and Services
2.8.4 Shandong Taibang Biological Products Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Shandong Taibang Biological Products Recent Developments/Updates
2.9 Shanghai Xinxing Medicine
2.9.1 Shanghai Xinxing Medicine Details
2.9.2 Shanghai Xinxing Medicine Major Business
2.9.3 Shanghai Xinxing Medicine Human Factor VIII Concentrate Product and Services
2.9.4 Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Shanghai Xinxing Medicine Recent Developments/Updates
2.10 SinoCell Tech
2.10.1 SinoCell Tech Details
2.10.2 SinoCell Tech Major Business
2.10.3 SinoCell Tech Human Factor VIII Concentrate Product and Services
2.10.4 SinoCell Tech Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 SinoCell Tech Recent Developments/Updates
2.11 CSL
2.11.1 CSL Details
2.11.2 CSL Major Business
2.11.3 CSL Human Factor VIII Concentrate Product and Services
2.11.4 CSL Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CSL Recent Developments/Updates
2.12 Grifols
2.12.1 Grifols Details
2.12.2 Grifols Major Business
2.12.3 Grifols Human Factor VIII Concentrate Product and Services
2.12.4 Grifols Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Grifols Recent Developments/Updates
2.13 Biogen
2.13.1 Biogen Details
2.13.2 Biogen Major Business
2.13.3 Biogen Human Factor VIII Concentrate Product and Services
2.13.4 Biogen Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Biogen Recent Developments/Updates
2.14 Octapharma
2.14.1 Octapharma Details
2.14.2 Octapharma Major Business
2.14.3 Octapharma Human Factor VIII Concentrate Product and Services
2.14.4 Octapharma Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Octapharma Recent Developments/Updates
2.15 NovoNordisk
2.15.1 NovoNordisk Details
2.15.2 NovoNordisk Major Business
2.15.3 NovoNordisk Human Factor VIII Concentrate Product and Services
2.15.4 NovoNordisk Human Factor VIII Concentrate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 NovoNordisk Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN FACTOR VIII CONCENTRATE BY MANUFACTURER
3.1 Global Human Factor VIII Concentrate Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Factor VIII Concentrate Revenue by Manufacturer (2018-2023)
3.3 Global Human Factor VIII Concentrate Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Factor VIII Concentrate by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Factor VIII Concentrate Manufacturer Market Share in 2022
3.4.2 Top 6 Human Factor VIII Concentrate Manufacturer Market Share in 2022
3.5 Human Factor VIII Concentrate Market: Overall Company Footprint Analysis
3.5.1 Human Factor VIII Concentrate Market: Region Footprint
3.5.2 Human Factor VIII Concentrate Market: Company Product Type Footprint
3.5.3 Human Factor VIII Concentrate Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Factor VIII Concentrate Market Size by Region
4.1.1 Global Human Factor VIII Concentrate Sales Quantity by Region (2018-2029)
4.1.2 Global Human Factor VIII Concentrate Consumption Value by Region (2018-2029)
4.1.3 Global Human Factor VIII Concentrate Average Price by Region (2018-2029)
4.2 North America Human Factor VIII Concentrate Consumption Value (2018-2029)
4.3 Europe Human Factor VIII Concentrate Consumption Value (2018-2029)
4.4 Asia-Pacific Human Factor VIII Concentrate Consumption Value (2018-2029)
4.5 South America Human Factor VIII Concentrate Consumption Value (2018-2029)
4.6 Middle East and Africa Human Factor VIII Concentrate Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Factor VIII Concentrate Sales Quantity by Type (2018-2029)
5.2 Global Human Factor VIII Concentrate Consumption Value by Type (2018-2029)
5.3 Global Human Factor VIII Concentrate Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Factor VIII Concentrate Sales Quantity by Application (2018-2029)
6.2 Global Human Factor VIII Concentrate Consumption Value by Application (2018-2029)
6.3 Global Human Factor VIII Concentrate Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Human Factor VIII Concentrate Sales Quantity by Type (2018-2029)
7.2 North America Human Factor VIII Concentrate Sales Quantity by Application (2018-2029)
7.3 North America Human Factor VIII Concentrate Market Size by Country
7.3.1 North America Human Factor VIII Concentrate Sales Quantity by Country (2018-2029)
7.3.2 North America Human Factor VIII Concentrate Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Human Factor VIII Concentrate Sales Quantity by Type (2018-2029)
8.2 Europe Human Factor VIII Concentrate Sales Quantity by Application (2018-2029)
8.3 Europe Human Factor VIII Concentrate Market Size by Country
8.3.1 Europe Human Factor VIII Concentrate Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Factor VIII Concentrate Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Factor VIII Concentrate Market Size by Region
9.3.1 Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Factor VIII Concentrate Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Human Factor VIII Concentrate Sales Quantity by Type (2018-2029)
10.2 South America Human Factor VIII Concentrate Sales Quantity by Application (2018-2029)
10.3 South America Human Factor VIII Concentrate Market Size by Country
10.3.1 South America Human Factor VIII Concentrate Sales Quantity by Country (2018-2029)
10.3.2 South America Human Factor VIII Concentrate Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Factor VIII Concentrate Market Size by Country
11.3.1 Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Factor VIII Concentrate Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Human Factor VIII Concentrate Market Drivers
12.2 Human Factor VIII Concentrate Market Restraints
12.3 Human Factor VIII Concentrate Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Factor VIII Concentrate and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Factor VIII Concentrate
13.3 Human Factor VIII Concentrate Production Process
13.4 Human Factor VIII Concentrate Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Factor VIII Concentrate Typical Distributors
14.3 Human Factor VIII Concentrate Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Human Factor VIII Concentrate Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Factor VIII Concentrate Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Human Factor VIII Concentrate Product and Services
Table 6. Pfizer Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 9. Novo Nordisk A/S Major Business
Table 10. Novo Nordisk A/S Human Factor VIII Concentrate Product and Services
Table 11. Novo Nordisk A/S Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Novo Nordisk A/S Recent Developments/Updates
Table 13. Shire (Baxter) Basic Information, Manufacturing Base and Competitors
Table 14. Shire (Baxter) Major Business
Table 15. Shire (Baxter) Human Factor VIII Concentrate Product and Services
Table 16. Shire (Baxter) Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Shire (Baxter) Recent Developments/Updates
Table 18. Bayer Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Major Business
Table 20. Bayer Human Factor VIII Concentrate Product and Services
Table 21. Bayer Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bayer Recent Developments/Updates
Table 23. GC Pharma Basic Information, Manufacturing Base and Competitors
Table 24. GC Pharma Major Business
Table 25. GC Pharma Human Factor VIII Concentrate Product and Services
Table 26. GC Pharma Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. GC Pharma Recent Developments/Updates
Table 28. Shanghai Raas Corp Basic Information, Manufacturing Base and Competitors
Table 29. Shanghai Raas Corp Major Business
Table 30. Shanghai Raas Corp Human Factor VIII Concentrate Product and Services
Table 31. Shanghai Raas Corp Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Shanghai Raas Corp Recent Developments/Updates
Table 33. Hualan Biological Basic Information, Manufacturing Base and Competitors
Table 34. Hualan Biological Major Business
Table 35. Hualan Biological Human Factor VIII Concentrate Product and Services
Table 36. Hualan Biological Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hualan Biological Recent Developments/Updates
Table 38. Shandong Taibang Biological Products Basic Information, Manufacturing Base and Competitors
Table 39. Shandong Taibang Biological Products Major Business
Table 40. Shandong Taibang Biological Products Human Factor VIII Concentrate Product and Services
Table 41. Shandong Taibang Biological Products Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Shandong Taibang Biological Products Recent Developments/Updates
Table 43. Shanghai Xinxing Medicine Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai Xinxing Medicine Major Business
Table 45. Shanghai Xinxing Medicine Human Factor VIII Concentrate Product and Services
Table 46. Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Shanghai Xinxing Medicine Recent Developments/Updates
Table 48. SinoCell Tech Basic Information, Manufacturing Base and Competitors
Table 49. SinoCell Tech Major Business
Table 50. SinoCell Tech Human Factor VIII Concentrate Product and Services
Table 51. SinoCell Tech Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. SinoCell Tech Recent Developments/Updates
Table 53. CSL Basic Information, Manufacturing Base and Competitors
Table 54. CSL Major Business
Table 55. CSL Human Factor VIII Concentrate Product and Services
Table 56. CSL Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CSL Recent Developments/Updates
Table 58. Grifols Basic Information, Manufacturing Base and Competitors
Table 59. Grifols Major Business
Table 60. Grifols Human Factor VIII Concentrate Product and Services
Table 61. Grifols Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Grifols Recent Developments/Updates
Table 63. Biogen Basic Information, Manufacturing Base and Competitors
Table 64. Biogen Major Business
Table 65. Biogen Human Factor VIII Concentrate Product and Services
Table 66. Biogen Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Biogen Recent Developments/Updates
Table 68. Octapharma Basic Information, Manufacturing Base and Competitors
Table 69. Octapharma Major Business
Table 70. Octapharma Human Factor VIII Concentrate Product and Services
Table 71. Octapharma Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Octapharma Recent Developments/Updates
Table 73. NovoNordisk Basic Information, Manufacturing Base and Competitors
Table 74. NovoNordisk Major Business
Table 75. NovoNordisk Human Factor VIII Concentrate Product and Services
Table 76. NovoNordisk Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. NovoNordisk Recent Developments/Updates
Table 78. Global Human Factor VIII Concentrate Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Human Factor VIII Concentrate Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Human Factor VIII Concentrate Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Human Factor VIII Concentrate, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Human Factor VIII Concentrate Production Site of Key Manufacturer
Table 83. Human Factor VIII Concentrate Market: Company Product Type Footprint
Table 84. Human Factor VIII Concentrate Market: Company Product Application Footprint
Table 85. Human Factor VIII Concentrate New Market Entrants and Barriers to Market Entry
Table 86. Human Factor VIII Concentrate Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Human Factor VIII Concentrate Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Human Factor VIII Concentrate Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Human Factor VIII Concentrate Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Human Factor VIII Concentrate Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Human Factor VIII Concentrate Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Human Factor VIII Concentrate Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Human Factor VIII Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Human Factor VIII Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Human Factor VIII Concentrate Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Human Factor VIII Concentrate Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Human Factor VIII Concentrate Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Human Factor VIII Concentrate Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Human Factor VIII Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Human Factor VIII Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Human Factor VIII Concentrate Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Human Factor VIII Concentrate Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Human Factor VIII Concentrate Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Human Factor VIII Concentrate Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Human Factor VIII Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Human Factor VIII Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Human Factor VIII Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Human Factor VIII Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Human Factor VIII Concentrate Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Human Factor VIII Concentrate Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Human Factor VIII Concentrate Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Human Factor VIII Concentrate Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Human Factor VIII Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Human Factor VIII Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Human Factor VIII Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Human Factor VIII Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Human Factor VIII Concentrate Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Human Factor VIII Concentrate Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Human Factor VIII Concentrate Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Human Factor VIII Concentrate Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Human Factor VIII Concentrate Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Human Factor VIII Concentrate Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Human Factor VIII Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Human Factor VIII Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Human Factor VIII Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Human Factor VIII Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Human Factor VIII Concentrate Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Human Factor VIII Concentrate Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Human Factor VIII Concentrate Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Human Factor VIII Concentrate Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Human Factor VIII Concentrate Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Human Factor VIII Concentrate Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Human Factor VIII Concentrate Raw Material
Table 146. Key Manufacturers of Human Factor VIII Concentrate Raw Materials
Table 147. Human Factor VIII Concentrate Typical Distributors
Table 148. Human Factor VIII Concentrate Typical Customers
Table 1. Global Human Factor VIII Concentrate Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Factor VIII Concentrate Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Human Factor VIII Concentrate Product and Services
Table 6. Pfizer Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 9. Novo Nordisk A/S Major Business
Table 10. Novo Nordisk A/S Human Factor VIII Concentrate Product and Services
Table 11. Novo Nordisk A/S Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Novo Nordisk A/S Recent Developments/Updates
Table 13. Shire (Baxter) Basic Information, Manufacturing Base and Competitors
Table 14. Shire (Baxter) Major Business
Table 15. Shire (Baxter) Human Factor VIII Concentrate Product and Services
Table 16. Shire (Baxter) Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Shire (Baxter) Recent Developments/Updates
Table 18. Bayer Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Major Business
Table 20. Bayer Human Factor VIII Concentrate Product and Services
Table 21. Bayer Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bayer Recent Developments/Updates
Table 23. GC Pharma Basic Information, Manufacturing Base and Competitors
Table 24. GC Pharma Major Business
Table 25. GC Pharma Human Factor VIII Concentrate Product and Services
Table 26. GC Pharma Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. GC Pharma Recent Developments/Updates
Table 28. Shanghai Raas Corp Basic Information, Manufacturing Base and Competitors
Table 29. Shanghai Raas Corp Major Business
Table 30. Shanghai Raas Corp Human Factor VIII Concentrate Product and Services
Table 31. Shanghai Raas Corp Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Shanghai Raas Corp Recent Developments/Updates
Table 33. Hualan Biological Basic Information, Manufacturing Base and Competitors
Table 34. Hualan Biological Major Business
Table 35. Hualan Biological Human Factor VIII Concentrate Product and Services
Table 36. Hualan Biological Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hualan Biological Recent Developments/Updates
Table 38. Shandong Taibang Biological Products Basic Information, Manufacturing Base and Competitors
Table 39. Shandong Taibang Biological Products Major Business
Table 40. Shandong Taibang Biological Products Human Factor VIII Concentrate Product and Services
Table 41. Shandong Taibang Biological Products Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Shandong Taibang Biological Products Recent Developments/Updates
Table 43. Shanghai Xinxing Medicine Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai Xinxing Medicine Major Business
Table 45. Shanghai Xinxing Medicine Human Factor VIII Concentrate Product and Services
Table 46. Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Shanghai Xinxing Medicine Recent Developments/Updates
Table 48. SinoCell Tech Basic Information, Manufacturing Base and Competitors
Table 49. SinoCell Tech Major Business
Table 50. SinoCell Tech Human Factor VIII Concentrate Product and Services
Table 51. SinoCell Tech Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. SinoCell Tech Recent Developments/Updates
Table 53. CSL Basic Information, Manufacturing Base and Competitors
Table 54. CSL Major Business
Table 55. CSL Human Factor VIII Concentrate Product and Services
Table 56. CSL Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CSL Recent Developments/Updates
Table 58. Grifols Basic Information, Manufacturing Base and Competitors
Table 59. Grifols Major Business
Table 60. Grifols Human Factor VIII Concentrate Product and Services
Table 61. Grifols Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Grifols Recent Developments/Updates
Table 63. Biogen Basic Information, Manufacturing Base and Competitors
Table 64. Biogen Major Business
Table 65. Biogen Human Factor VIII Concentrate Product and Services
Table 66. Biogen Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Biogen Recent Developments/Updates
Table 68. Octapharma Basic Information, Manufacturing Base and Competitors
Table 69. Octapharma Major Business
Table 70. Octapharma Human Factor VIII Concentrate Product and Services
Table 71. Octapharma Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Octapharma Recent Developments/Updates
Table 73. NovoNordisk Basic Information, Manufacturing Base and Competitors
Table 74. NovoNordisk Major Business
Table 75. NovoNordisk Human Factor VIII Concentrate Product and Services
Table 76. NovoNordisk Human Factor VIII Concentrate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. NovoNordisk Recent Developments/Updates
Table 78. Global Human Factor VIII Concentrate Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Human Factor VIII Concentrate Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Human Factor VIII Concentrate Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Human Factor VIII Concentrate, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Human Factor VIII Concentrate Production Site of Key Manufacturer
Table 83. Human Factor VIII Concentrate Market: Company Product Type Footprint
Table 84. Human Factor VIII Concentrate Market: Company Product Application Footprint
Table 85. Human Factor VIII Concentrate New Market Entrants and Barriers to Market Entry
Table 86. Human Factor VIII Concentrate Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Human Factor VIII Concentrate Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Human Factor VIII Concentrate Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Human Factor VIII Concentrate Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Human Factor VIII Concentrate Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Human Factor VIII Concentrate Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Human Factor VIII Concentrate Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Human Factor VIII Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Human Factor VIII Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Human Factor VIII Concentrate Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Human Factor VIII Concentrate Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Human Factor VIII Concentrate Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Human Factor VIII Concentrate Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Human Factor VIII Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Human Factor VIII Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Human Factor VIII Concentrate Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Human Factor VIII Concentrate Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Human Factor VIII Concentrate Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Human Factor VIII Concentrate Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Human Factor VIII Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Human Factor VIII Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Human Factor VIII Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Human Factor VIII Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Human Factor VIII Concentrate Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Human Factor VIII Concentrate Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Human Factor VIII Concentrate Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Human Factor VIII Concentrate Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Human Factor VIII Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Human Factor VIII Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Human Factor VIII Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Human Factor VIII Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Human Factor VIII Concentrate Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Human Factor VIII Concentrate Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Human Factor VIII Concentrate Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Human Factor VIII Concentrate Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Human Factor VIII Concentrate Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Human Factor VIII Concentrate Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Human Factor VIII Concentrate Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Human Factor VIII Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Human Factor VIII Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Human Factor VIII Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Human Factor VIII Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Human Factor VIII Concentrate Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Human Factor VIII Concentrate Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Human Factor VIII Concentrate Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Human Factor VIII Concentrate Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Human Factor VIII Concentrate Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Human Factor VIII Concentrate Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Human Factor VIII Concentrate Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Human Factor VIII Concentrate Raw Material
Table 146. Key Manufacturers of Human Factor VIII Concentrate Raw Materials
Table 147. Human Factor VIII Concentrate Typical Distributors
Table 148. Human Factor VIII Concentrate Typical Customers
LIST OF FIGURES
Figure 1. Human Factor VIII Concentrate Picture
Figure 2. Global Human Factor VIII Concentrate Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Factor VIII Concentrate Consumption Value Market Share by Type in 2022
Figure 4. Blood Extraction Examples
Figure 5. Recombine Examples
Figure 6. Global Human Factor VIII Concentrate Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Human Factor VIII Concentrate Consumption Value Market Share by Application in 2022
Figure 8. Congenital Coagulation Factor VIII Deficiency Examples
Figure 9. Acquired Factor VIII Deficiency Examples
Figure 10. Von Willebrand's Disease Examples
Figure 11. Global Human Factor VIII Concentrate Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Human Factor VIII Concentrate Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Human Factor VIII Concentrate Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Human Factor VIII Concentrate Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Human Factor VIII Concentrate Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Human Factor VIII Concentrate Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Human Factor VIII Concentrate by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Human Factor VIII Concentrate Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Human Factor VIII Concentrate Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Human Factor VIII Concentrate Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Human Factor VIII Concentrate Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Human Factor VIII Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Human Factor VIII Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Human Factor VIII Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Human Factor VIII Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Human Factor VIII Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Human Factor VIII Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Human Factor VIII Concentrate Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Human Factor VIII Concentrate Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Human Factor VIII Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Human Factor VIII Concentrate Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Human Factor VIII Concentrate Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Human Factor VIII Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Human Factor VIII Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Human Factor VIII Concentrate Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Human Factor VIII Concentrate Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Human Factor VIII Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Human Factor VIII Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Human Factor VIII Concentrate Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Human Factor VIII Concentrate Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Human Factor VIII Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Human Factor VIII Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Human Factor VIII Concentrate Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Human Factor VIII Concentrate Consumption Value Market Share by Region (2018-2029)
Figure 53. China Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Human Factor VIII Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Human Factor VIII Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Human Factor VIII Concentrate Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Human Factor VIII Concentrate Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Human Factor VIII Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Human Factor VIII Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Human Factor VIII Concentrate Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Human Factor VIII Concentrate Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Human Factor VIII Concentrate Market Drivers
Figure 74. Human Factor VIII Concentrate Market Restraints
Figure 75. Human Factor VIII Concentrate Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Human Factor VIII Concentrate in 2022
Figure 78. Manufacturing Process Analysis of Human Factor VIII Concentrate
Figure 79. Human Factor VIII Concentrate Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Human Factor VIII Concentrate Picture
Figure 2. Global Human Factor VIII Concentrate Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Factor VIII Concentrate Consumption Value Market Share by Type in 2022
Figure 4. Blood Extraction Examples
Figure 5. Recombine Examples
Figure 6. Global Human Factor VIII Concentrate Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Human Factor VIII Concentrate Consumption Value Market Share by Application in 2022
Figure 8. Congenital Coagulation Factor VIII Deficiency Examples
Figure 9. Acquired Factor VIII Deficiency Examples
Figure 10. Von Willebrand's Disease Examples
Figure 11. Global Human Factor VIII Concentrate Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Human Factor VIII Concentrate Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Human Factor VIII Concentrate Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Human Factor VIII Concentrate Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Human Factor VIII Concentrate Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Human Factor VIII Concentrate Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Human Factor VIII Concentrate by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Human Factor VIII Concentrate Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Human Factor VIII Concentrate Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Human Factor VIII Concentrate Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Human Factor VIII Concentrate Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Human Factor VIII Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Human Factor VIII Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Human Factor VIII Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Human Factor VIII Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Human Factor VIII Concentrate Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Human Factor VIII Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Human Factor VIII Concentrate Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Human Factor VIII Concentrate Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Human Factor VIII Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Human Factor VIII Concentrate Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Human Factor VIII Concentrate Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Human Factor VIII Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Human Factor VIII Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Human Factor VIII Concentrate Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Human Factor VIII Concentrate Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Human Factor VIII Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Human Factor VIII Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Human Factor VIII Concentrate Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Human Factor VIII Concentrate Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Human Factor VIII Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Human Factor VIII Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Human Factor VIII Concentrate Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Human Factor VIII Concentrate Consumption Value Market Share by Region (2018-2029)
Figure 53. China Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Human Factor VIII Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Human Factor VIII Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Human Factor VIII Concentrate Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Human Factor VIII Concentrate Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Human Factor VIII Concentrate Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Human Factor VIII Concentrate Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Human Factor VIII Concentrate Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Human Factor VIII Concentrate Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Human Factor VIII Concentrate Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Human Factor VIII Concentrate Market Drivers
Figure 74. Human Factor VIII Concentrate Market Restraints
Figure 75. Human Factor VIII Concentrate Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Human Factor VIII Concentrate in 2022
Figure 78. Manufacturing Process Analysis of Human Factor VIII Concentrate
Figure 79. Human Factor VIII Concentrate Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
